Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lake

Showing results (201-210 of 388) with videos related to

Pageof 39
Sort By:
International Journal of Cancer|December 18, 2001
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancerS L Kominsky, B A Torres, A C Hobeika, et al.
Biopharmaceutics & Drug Disposition|March 23, 1999
Bioavailability of carbamazepine from four different products and the occurrence of side effectsM Olling, T T Mensinga, D M Barends, et al.
Science (New York, N.Y.)|August 3, 1984
A new ribosome structureE Henderson, M Oakes, M W Clark, et al.
Plos One|March 18, 2017
Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52A Lake Wooten, Tolulope A Aweda, Benjamin C Lewis, et al.
International Reviews of Immunology|July 19, 2012
The use of agonistic anti-CD40 therapy in treatments for cancerAndrea Khong, Delia J Nelson, Anna K Nowak, et al.
International Journal of Pediatrics|May 17, 2019
Magnitude of Neonatal Jaundice and Its Associated Factor in Neonatal Intensive Care Units of Mekelle City Public Hospitals, Northern EthiopiaEyasu A Lake, Gerezgiher B Abera, Gedion A Azeze, et al.
Clinical & Developmental Immunology|May 22, 2012
Programmed death ligand 2 in cancer-induced immune suppressionEsdy N Rozali, Stanleyson V Hato, Bruce W Robinson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitorsTarek M Meniawy, Richard A Lake, Alison M McDonnell, et al.
Cancer Research|August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cellsS L Kominsky, A C Hobeika, F A Lake, et al.
Immunology and Cell Biology|November 26, 1999
Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulationB W Robinson, R A Lake, D J Nelson, et al.
Pageof 39

Showing results (201-210 of 388) with videos related to

Sort By:
Pageof 39
International Journal of Cancer|December 18, 2001
Superantigen enhanced protection against a weak tumor-specific melanoma antigen: implications for prophylactic vaccination against cancerS L Kominsky, B A Torres, A C Hobeika, et al.
Biopharmaceutics & Drug Disposition|March 23, 1999
Bioavailability of carbamazepine from four different products and the occurrence of side effectsM Olling, T T Mensinga, D M Barends, et al.
Science (New York, N.Y.)|August 3, 1984
A new ribosome structureE Henderson, M Oakes, M W Clark, et al.
Plos One|March 18, 2017
Biodistribution and PET Imaging of pharmacokinetics of manganese in mice using Manganese-52A Lake Wooten, Tolulope A Aweda, Benjamin C Lewis, et al.
International Reviews of Immunology|July 19, 2012
The use of agonistic anti-CD40 therapy in treatments for cancerAndrea Khong, Delia J Nelson, Anna K Nowak, et al.
International Journal of Pediatrics|May 17, 2019
Magnitude of Neonatal Jaundice and Its Associated Factor in Neonatal Intensive Care Units of Mekelle City Public Hospitals, Northern EthiopiaEyasu A Lake, Gerezgiher B Abera, Gedion A Azeze, et al.
Clinical & Developmental Immunology|May 22, 2012
Programmed death ligand 2 in cancer-induced immune suppressionEsdy N Rozali, Stanleyson V Hato, Bruce W Robinson, et al.
Lung Cancer (Amsterdam, Netherlands)|February 23, 2016
PD-L1 on peripheral blood T lymphocytes is prognostic in patients with non-small cell lung cancer (NSCLC) treated with EGFR inhibitorsTarek M Meniawy, Richard A Lake, Alison M McDonnell, et al.
Cancer Research|August 5, 2000
Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cellsS L Kominsky, A C Hobeika, F A Lake, et al.
Immunology and Cell Biology|November 26, 1999
Cross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulationB W Robinson, R A Lake, D J Nelson, et al.
Pageof 39